The Fund aims to achieve long term capital growth.
Name | % Net Assets |
---|---|
Vodafone Group | 7.9% |
HSBC Hldgs | 5.5% |
Astrazeneca | 3.8% |
ROTH & RAU AG | 3.1% |
Scottish & Southern Energy | 2.7% |
Barclays | 2.6% |
Q-cells | 2.5% |
Centrica | 2.4% |
Danone | 2.0% |
Royal Bank Of Scotland Group | 2.0% |
Key | % Net Assets |
---|---|
Vodafone Group | 7.9% |
HSBC Hldgs | 5.5% |
Astrazeneca | 3.8% |
ROTH & RAU AG | 3.1% |
Other | 79.7% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 01/11/2000 |
---|---|
Fund Manager | Alex Illingworth |
TER | - |
Minimum Investment | |
---|---|
Initial | 2000 |
Additional | n/a |
Savings | 100 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.15 |
You are here: research